<DOC>
	<DOCNO>NCT02375217</DOCNO>
	<brief_summary>Prospective Randomized non inferiority Trial involve adult patient undergo elective surgery general anesthesia.56 Patients enrol 2 group : full dose sugammadex vs half dose sugammadex reversal NMB .</brief_summary>
	<brief_title>`` Low Dose Sugammadex Combined With Neostigmine Glycopyrrolate Versus Full Dose Sugammadex Reversal Rocuronium-induced Neuromuscular Blockade : Cost Saving Strategy ''</brief_title>
	<detailed_description>The investigator ' aim prove half dose sugammadex combination neostigmine 0.05 mg/kg non-inferior recommend dose sugammadex reversal deep ( absence Trian Four response : TOF ) moderate ( TOF 1 2 twiches ) muscle paralysis patient undergo surgery general anesthesia .</detailed_description>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>Patients age 1870 ASA class I , II , III undergo surgery balance general anesthesia require use muscle relaxant throughout surgery patient undergo emergency surgery pregnant patient patient end stage renal disease chronic kidney disease ( GFR less 60 ) patient allergy sugammadex previous complication side effect previous sugammadex administration patient ' refusal patient allergy recuronium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>